vs

Side-by-side financial comparison of Labcorp (LH) and Nasdaq, Inc. (NDAQ). Click either name above to swap in a different company.

Labcorp is the larger business by last-quarter revenue ($3.5B vs $2.1B, roughly 1.7× Nasdaq, Inc.). Nasdaq, Inc. runs the higher net margin — 24.3% vs 7.9%, a 16.4% gap on every dollar of revenue. On growth, Labcorp posted the faster year-over-year revenue change (5.8% vs 2.0%). Over the past eight quarters, Nasdaq, Inc.'s revenue compounded faster (9.2% CAGR vs 4.8%).

Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.

Nasdaq Stock Market is an American stock exchange, the second-largest by market cap on the list of stock exchanges, and the first fully electronic stock market. The exchange is based in Manhattan, New York City, and is among the most active stock trading venue by volume in the United States.

LH vs NDAQ — Head-to-Head

Bigger by revenue
LH
LH
1.7× larger
LH
$3.5B
$2.1B
NDAQ
Growing faster (revenue YoY)
LH
LH
+3.8% gap
LH
5.8%
2.0%
NDAQ
Higher net margin
NDAQ
NDAQ
16.4% more per $
NDAQ
24.3%
7.9%
LH
Faster 2-yr revenue CAGR
NDAQ
NDAQ
Annualised
NDAQ
9.2%
4.8%
LH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
LH
LH
NDAQ
NDAQ
Revenue
$3.5B
$2.1B
Net Profit
$277.8M
$519.0M
Gross Margin
28.7%
Operating Margin
10.8%
30.7%
Net Margin
7.9%
24.3%
Revenue YoY
5.8%
2.0%
Net Profit YoY
30.5%
31.4%
EPS (diluted)
$3.35
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LH
LH
NDAQ
NDAQ
Q1 26
$3.5B
$2.1B
Q4 25
$3.5B
$2.1B
Q3 25
$3.6B
$2.0B
Q2 25
$3.5B
$2.1B
Q1 25
$3.3B
$2.1B
Q4 24
$3.3B
$2.0B
Q3 24
$3.3B
$1.9B
Q2 24
$3.2B
$1.8B
Net Profit
LH
LH
NDAQ
NDAQ
Q1 26
$277.8M
$519.0M
Q4 25
$164.7M
$518.0M
Q3 25
$261.1M
$423.0M
Q2 25
$237.9M
$452.0M
Q1 25
$212.8M
$395.0M
Q4 24
$143.4M
$355.0M
Q3 24
$169.3M
$306.0M
Q2 24
$205.3M
$222.0M
Gross Margin
LH
LH
NDAQ
NDAQ
Q1 26
28.7%
Q4 25
28.2%
65.5%
Q3 25
28.8%
67.2%
Q2 25
29.7%
62.5%
Q1 25
28.3%
59.2%
Q4 24
26.9%
60.4%
Q3 24
27.6%
60.3%
Q2 24
28.8%
64.7%
Operating Margin
LH
LH
NDAQ
NDAQ
Q1 26
10.8%
30.7%
Q4 25
7.6%
29.7%
Q3 25
11.1%
29.9%
Q2 25
11.2%
27.2%
Q1 25
9.7%
26.2%
Q4 24
6.5%
25.4%
Q3 24
7.7%
23.6%
Q2 24
9.2%
23.6%
Net Margin
LH
LH
NDAQ
NDAQ
Q1 26
7.9%
24.3%
Q4 25
4.7%
24.4%
Q3 25
7.3%
21.6%
Q2 25
6.7%
21.6%
Q1 25
6.4%
18.9%
Q4 24
4.3%
17.5%
Q3 24
5.2%
16.1%
Q2 24
6.4%
12.4%
EPS (diluted)
LH
LH
NDAQ
NDAQ
Q1 26
$3.35
$0.91
Q4 25
$1.98
$0.90
Q3 25
$3.12
$0.73
Q2 25
$2.84
$0.78
Q1 25
$2.52
$0.68
Q4 24
$1.72
$0.62
Q3 24
$2.00
$0.53
Q2 24
$2.43
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LH
LH
NDAQ
NDAQ
Cash + ST InvestmentsLiquidity on hand
$981.1M
$515.0M
Total DebtLower is stronger
$5.8B
$9.0B
Stockholders' EquityBook value
$8.7B
$12.0B
Total Assets
$19.1B
$27.3B
Debt / EquityLower = less leverage
0.67×
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LH
LH
NDAQ
NDAQ
Q1 26
$981.1M
$515.0M
Q4 25
$532.3M
$604.0M
Q3 25
$598.1M
$470.0M
Q2 25
$647.3M
$732.0M
Q1 25
$369.4M
$690.0M
Q4 24
$1.5B
$592.0M
Q3 24
$1.5B
$266.0M
Q2 24
$265.1M
$416.0M
Total Debt
LH
LH
NDAQ
NDAQ
Q1 26
$5.8B
$9.0B
Q4 25
$8.6B
Q3 25
$8.7B
Q2 25
$8.7B
Q1 25
$8.9B
Q4 24
$9.1B
Q3 24
$9.4B
Q2 24
$9.2B
Stockholders' Equity
LH
LH
NDAQ
NDAQ
Q1 26
$8.7B
$12.0B
Q4 25
$8.6B
$12.2B
Q3 25
$8.7B
$12.0B
Q2 25
$8.5B
$11.8B
Q1 25
$8.3B
$11.5B
Q4 24
$8.1B
$11.2B
Q3 24
$8.2B
$11.1B
Q2 24
$8.0B
$10.9B
Total Assets
LH
LH
NDAQ
NDAQ
Q1 26
$19.1B
$27.3B
Q4 25
$18.4B
$31.1B
Q3 25
$18.3B
$30.7B
Q2 25
$18.1B
$30.4B
Q1 25
$17.6B
$30.6B
Q4 24
$18.4B
$30.4B
Q3 24
$18.6B
$30.6B
Q2 24
$16.7B
$30.2B
Debt / Equity
LH
LH
NDAQ
NDAQ
Q1 26
0.67×
0.74×
Q4 25
0.70×
Q3 25
0.72×
Q2 25
0.73×
Q1 25
0.77×
Q4 24
0.81×
Q3 24
0.85×
Q2 24
0.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LH
LH
NDAQ
NDAQ
Operating Cash FlowLast quarter
$191.5M
Free Cash FlowOCF − Capex
$70.5M
FCF MarginFCF / Revenue
2.0%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
0.69×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LH
LH
NDAQ
NDAQ
Q1 26
$191.5M
Q4 25
$614.2M
$625.0M
Q3 25
$387.2M
$221.0M
Q2 25
$620.6M
$746.0M
Q1 25
$18.5M
$663.0M
Q4 24
$777.2M
$705.0M
Q3 24
$277.3M
$244.0M
Q2 24
$561.1M
$460.0M
Free Cash Flow
LH
LH
NDAQ
NDAQ
Q1 26
$70.5M
Q4 25
$490.3M
$536.0M
Q3 25
$280.5M
$152.0M
Q2 25
$542.7M
$687.0M
Q1 25
$-107.5M
$614.0M
Q4 24
$665.1M
$645.0M
Q3 24
$161.5M
$188.0M
Q2 24
$432.9M
$408.0M
FCF Margin
LH
LH
NDAQ
NDAQ
Q1 26
2.0%
Q4 25
13.9%
25.2%
Q3 25
7.9%
7.8%
Q2 25
15.4%
32.9%
Q1 25
-3.2%
29.4%
Q4 24
20.0%
31.7%
Q3 24
4.9%
9.9%
Q2 24
13.4%
22.8%
Capex Intensity
LH
LH
NDAQ
NDAQ
Q1 26
3.4%
Q4 25
3.5%
4.2%
Q3 25
3.0%
3.5%
Q2 25
2.2%
2.8%
Q1 25
3.8%
2.3%
Q4 24
3.4%
3.0%
Q3 24
3.5%
2.9%
Q2 24
4.0%
2.9%
Cash Conversion
LH
LH
NDAQ
NDAQ
Q1 26
0.69×
Q4 25
3.73×
1.21×
Q3 25
1.48×
0.52×
Q2 25
2.61×
1.65×
Q1 25
0.09×
1.68×
Q4 24
5.42×
1.99×
Q3 24
1.64×
0.80×
Q2 24
2.73×
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LH
LH

Revenues$2.8B78%
Other$775.5M22%

NDAQ
NDAQ

Market Services$1.0B49%
Capital Access Platforms$565.0M26%
Financial Technology$517.0M24%
Other Revenues$8.0M0%

Related Comparisons